Lack of effect of calcitonin gene-related peptide and amylin on major markers of glucose metabolism in hepatocytes

European Journal of Pharmacology

Volumn 325, Issue 2-3, 1997, Pages 189-197

  Pittner, Richard A ^a  

^a AMYLIN PHARMACEUTICALS INC   (United States)

Author keywords

Amylin; CGRP (calcitonin gene related peptide); Glucose metabolism; Hepatocyte; Kupffer cell; Macrophage

Indexed keywords

AMYLIN; CALCITONIN GENE RELATED PEPTIDE; CYCLIC AMP; LACTIC ACID;

ANIMAL CELL; ARTICLE; BINDING SITE; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; GLUCOSE METABOLISM; GLYCOGEN SYNTHESIS; KUPFFER CELL; LIVER CELL; LUNG ALVEOLUS MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; RAT;

AMYLOID; ANIMALS; BINDING SITES; BIOLOGICAL MARKERS; CALCITONIN GENE-RELATED PEPTIDE; CELLS, CULTURED; CYCLIC AMP; ENDOTHELIUM; ENZYME ACTIVATION; ENZYME INDUCTION; GLUCONEOGENESIS; GLUCOSE; HUMANS; KUPFFER CELLS; LACTIC ACID; LIVER; LIVER GLYCOGEN; MACROPHAGES, ALVEOLAR; PHOSPHORYLASES; RATS; TYROSINE TRANSAMINASE;

EID: 0030917598     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)00132-5     Document Type: Article

References (52)

1. Baque, S., J.J. Guinovart and A.M. Gómez-Foix, 1994, Amylin impairment of insulin effects on glycogen synthesis and phosphoenolpyruvate carboxykinase gene expression in rat primary cultured hepatocytes, Biochem. J. 304, 449.
2. Berry, M.N. and D.S. Friend, 1969, High yield preparation of isolated rat liver parenchymal cells. A biochemical and fine structural study, J. Cell. Biol. 43, 506.
3. Bradford, M.M., 1976, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem. 72, 248.
4. Brass, E.P. and M.J. Garrity, 1990, Structural specificity for prostaglandin effects on hepatocyte glycogenolysis, Biochem. J. 267, 59.
5. Bushfield, M., A. Savage, N.J. Morris and M.D. Houslay, 1993, A mnemonical or negative co-operativity model for the activation of adenylate cyclase by a common G-protein coupled calcitonin related neuropeptide (CGRP)/amylin receptor, Biochem. J. 293, 229.
6. Casteleijn, E., J.L. Kuiper, H.C.J. Van Rooij, J.A.A.M. Kamps, J.F. Koster and T.J.C. Van Berkel, 1988a, Endotoxin stimulates glycogenolysis in the liver by means of intercellular communication, J. Biol. Chem. 263, 6953.
7. Casteleijn, E., J.L. Kuiper, H.C.J. Van Rooij, J.A.A.M. Kamps, J.F. Koster and T.J.C. Van Berkel, 1988b, Hormonal control of glycogenolysis in parenchymal liver cells by Kupffer cells and endothelial cells, J. Biol. Chem. 263, 2699.
8. Choi, S.B., S. Frontoni and L. Rossetti, 1991, Mechanism by which CGRP antagonises insulin action in vivo, Am. J. Physiol. 260, E321.
9. Ciaraldi, T.P., M. Goldberg, R. Odom and M. Stolpe, 1992, In vitro effects of amylin on carbohydrate metabolism in liver cells, Diabetes 41, 975.
10. Cooper, G.J.S., 1994, Amylin compared with calcitonin gene-related peptide: structure, biology and relevance to metabolic disease, Endoer. Rev. 15, 163.
11. Deems, R.O., R.W. Deacon and D.A. Young, 1991, Amylin activates glycogen phosphorylase and inactivates glycogen synthase via a cAMP-independent mechanism, Biochem. Biophys. Res. Commun. 174, 716.
12. Diamondstone, T.I., 1966, Assay of tyrosine transaminase activity by conversion of p-hydroxyphenylpyruvate to p-hydroxybenzaldehyde, Anal. Biochem. 16, 395.
13. Galeazza, M.T., T.D. O'Brien, K.H. Johnson and V.S. Seybold, 1991, Islet amyloid polypeptide (IAPP) competes for two binding sites of CGRP, Peptides 12, 585.
14. 2α affect glycogen synthase and phosphorylase in isolated hepatocytes, Biochem. J. 261, 93.
15. Gómez-Foix, A.M., J.E. Rodriguez-Gil and J.J. Guinovart, 1991, Anti-insulin effects of amylin and CGRP on hepatic glycogen metabolism, Biochem. J. 276, 607.
16. Hendriks, H.F.J., W.A.M.M. Verhoofstad, A. Brouwer, A.M. De Leeuw and D.L. Knook, 1985, Perisinusoidal fat storing cells are the main vitamin A storage sites in rat liver, Exp. Cell. Res. 160, 138.
17. Kenney, M.A., C.X. Moore, R.A. Pittner and K. Beaumont, 1993, Salmon calcitonin binding and stimulation of cyclic AMP generation in rat skeletal muscle, Biochem. Biophys. Res. Commun. 197, 8.
18. Koopmans, S.J., A.D.M. Van Mansfield, H.S. Jansz, H.M.J. Krans, J.K. Radder, M. Frolich, S.F. De Boer, D.K. Kreutter, G.C. Andrews and J.A. Maassen, 1991, Amylin-induced in vivo insulin resistance in conscious rats: the liver is more sensitive to amylin than peripheral tissues, Diabetologia 34, 218.
19. Leighton, B. and G.J.S. Cooper, 1988, Pancreatic amylin and CGRP cause resistance to insulin in skeletal muscle, Nature 335, 632.
20. Mayer, A.M.S., R.A. Pittner, G.E. Lipscomb and J.A. Spitzer, 1993, Effect of in vivo TNF administration on superoxide production and PKC activity of rat alveolar macrophages, Am. J. Physiol. 264, L43.
21. Molina, J.M., G.J.S. Cooper, B. Leighton and J.M. Olefsky, 1990, Induction of insulin resistance in vivo by amylin and CGRP peptide, Diabetes 39, 260.
22. Morishita, T., A. Yamaguchi, T. Fujita and T. Chiba, 1990, Activation of adenylate cyclase by IAP with COOH-terminal amide via CGRP related peptide receptors on rat liver plasma membranes, Diabetes 39, 875.
23. Morishita, T., A. Yamaguchi, T. Yamatani, A. Nakamura, N. Arima, Y. Yamashita, H. Nakata, T. Fujita and T. Chiba, 1992, Effects of islet amyloid polypeptide (amylin) and calcitonin gene related peptide (CGRP) on glucose metabolism in the rat, Diabetes Res. Clin. Pract. 15, 63.
24. Nishimura, S., T. Sanke, K. Machida, H. Bessho, T. Hanabusa, K. Nakai and K. Nanjo, 1992, Lack of effect of islet amyloid polypeptide on hepatic glucose output in the in situ perfused rat liver, Metabolism 41, 431.
25. Nouspikel, T., A. Gjinovci, S. Li and P.B. lynedjian, 1992, Unimpaired effect of insulin on glucokinase gene expression in hepatocytes challenged with amylin, FEBS Lett. 301, 115.
26. Owan, I. and K. Ibaraki, 1994, The role of CGRP in macrophages: the presence of functional receptors and effects on proliferation and differentiation into osteoclast like cells, Bone Miner. 24, 151.
27. Pittner, R.A. and J.A. Spitzer, 1993, LPS inhibits PI-phospholipase C but not PC-phospholipase D or phosphorylase activation by vasopressin and norepinephrine, Am. J. Physiol. 264, E465.
28. Pittner, R.A., R. Fears and D.N. Brindley, 1985, Effects of cAMP, glucocorticoids and insulin on the activities of PAP, tyrosine aminotransferase and glycerol kinase in isolated rat hepatocytes in relation to the control of triacylglycerol synthesis and gluconeogenesis, Biochem. J. 225, 455.
29. Pittner, R.A., K. Albrandt, K. Beaumont, L.S.L. Gaeta, J.E. Koda, C.X. Moore, J. Rittenhouse and T.J. Rink, 1994, Molecular physiology of amylin, J. Cell. Biochem. 55S, 19.
30. Pittner, R.A., K. Beaumont, A.A. Young and T.J. Rink, 1995, Dose-dependent elevation of cyclic AMP, activation of glycogen phosphorylase and release of lactate by amylin in rat skeletal muscle, Biochim. Biophys. Acta 1267, 75.
31. Poyner, D.R., D.P. Andrew, D. Brown, C. Bose and M.R. Hanley, 1992, Pharmacological characterisation of a receptor for calcitonin gene related peptide on rat L6 myocytes, Br. J. Pharmacol. 105, 441.
32. Rink, T.J., K. Beaumont, J.E. Koda and A.A. Young, 1993, Structure and biology of amylin, Trends Pharmacol. Sci. 14, 113.
33. Rink, T.J., E. Larson, A.A. Young and B. Gedulin, 1994, Effects of amylin on lactate metabolism in the rat: studies using hyperlactemic/hyperglycemic clamps, Diabetologia 37, A117 (Abstract).
34. Roden, M., K. Liener, C. Furnsinn, P. Nowotny, U. Hollenstein, H. Vierhapper and W. Waldhausl, 1992, Effects of amyloid polypeptide on hepatic insulin resistance and glucose production in the isolated perfused rat liver, Diabetologia 35, 116.
35. Rossetti, L., S. Farrace, S.B. Choi, A. Giaccari, L. Sloan, S. Frontoni and M.S. Katz, 1993, Multiple metabolic effects of CGRP in conscious rats: role of glycogen synthase and phosphorylase, Am. J. Physiol. 264, El.
36. Spitzer, J.A. and R.A. Pittner, 1993, Continuous non-lethal endotoxemia primes Kupffer and parenchymal liver cells for enhanced nitric oxide production in response to a subsequent endotoxin or TNF challenge in vitro, Cells Hepatic Sinusoid 4, 85.
37. Stephens, T.W., W.F. Heath and R.N. Hermeling, 1991, Presence of liver CGRP/amylin receptors in only non-parenchymal cells and absence of direct regulation of rat liver glucose metabolism by CGRP/amylin, Diabetes 40, 395.
38. Suzuki, S., M. Muramaki, S. Abe, Y. Satoh, S. Shintani, J. Ishizuka, K. Suzuki, J.C. Thompson and T. Toyota, 1992, The effects of amylin on insulin secretion from Rin m5F cells and glycogen synthesis and lipogenesis in rat primary cultured hepatocytes, Diabetes Res. Clin. Pract. 15, 77.
39. Vignery, A., M.J. Raymond, H.Y. Qian, F. Wang and S.A. Rosenzweig, 1991a, Multinucleated rat alveolar macrophages express functional receptors for calcitonin, Am. J. Physiol. 261, F1026.
40. Vignery, A., F. Wang and M.B. Ganz, 1991b, Macrophages express functional receptors for calcitonin gene related peptide, J. Cell. Physiol. 149, 301.
41. Vine, W., P. Smith, R. LaChappell, T.J. Rink and A.A. Young, 1995, Lactate production from the rat hindlimb is increased after glucose administration and is suppressed by a selective amylin antagonist: evidence for action of endogenous amylin in skeletal muscle, Biochem. Biophys. Res. Commun. 216, 554.
42. Wang, M.W., P. Carlo, T.J. Rink and A.A. Young, 1991, Amylin is more potent and more effective than glucagon in raising plasma glucose concentration in fasted, anesthetized rats, Biochem. Biophys. Res. Commun. 181, 1288.
43. West, M.A., T.R. Billiar, R.D. Curran, B.J. Hyland and R.L. Simmons, 1989, Evidence that rat Kupffer cells stimulate and inhibit hepatocyte protein synthesis in vitro by different mechanisms, Gastroenterology 96, 1572.
44. Young, D.A., R.O. Deems, R.W. Deacon, R.H. McIntosh and J.E. Foley, 1990, Effects of amylin on glucose metabolism and glycogenolysis in vivo and in vitro, Am. J. Physiol. 259, E457.
45. Young, A.A., L.B. Crocker, D. Wolfe-Lopez and G.J.S. Cooper, 1991a, Daily amylin replacement reverses hepatic glycogen depletion in insulin-treated streptozotocin diabetic rats, FEBS Lett. 287, 203.
46. Young, A.A., D.M. Mott, K. Stone and G.J.S. Cooper, 1991b, Amylin activates glycogen phosphorylase in isolated soleus muscle of the rat, FEBS Lett. 281, 149.
47. Young, A.A., M.W. Wang and G.J.S. Cooper, 1991c, Amylin injection causes elevated plasma lactate and glucose in rat, FEBS Lett. 291, 101.
48. Young, A.A., B. Gedulin, D. Wolfe-Lopez, H.E. Greene, T.J. Rink and G.J.S. Cooper, 1992, Amylin and insulin in rat soleus muscle: dose responses for cosecreted noncompetitive antagonists, Am. J. Physiol. 263, E274.
49. Young, A.A., T.J. Rink and M.W. Wang, 1993, Dose response characteristics for the hyperglycemic, hyperlactemic, hypotensive and hypocalcemic actions of amylin and calcitonin gene related peptide-1 (CGRPa) in the fasted, anaesthetized rat, Life Sci. 52, 1717.
50. Young, A.A., B. Gedulin, W. Vine, A. Percy and T.J. Rink, 1995a, Gastric emptying is accelerated in diabetic BB rats and is slowed by subcutaneous injections of amylin, Diabetologia 38, 642.
51. Young, A.A., R.A. Pittner, B. Gedulin, W. Vine and T.J. Rink, 1995b, Amylin regulation of carbohydrate metabolism, Biochem. Soc. Trans. 23, 325.
52. Zhu, G., D.T. Dudley and A.R. Saltiel, 1991, Amylin increases cAMP formation in L6 myocytes through CGRP receptors, Biochem. Biophys. Res. Commun. 177, 771.